Author:
Arabzadeh A,Chan C,Nouvion A-L,Breton V,Benlolo S,DeMarte L,Turbide C,Brodt P,Ferri L,Beauchemin N
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference48 articles.
1. Bamberger AM, Riethdorf L, Nollau P, Naumann M, Erdmann I, Gotze J et al. (1998). Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol 152: 1401–1406.
2. Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F et al. (1999). Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 252: 243–249.
3. Busch C, Hanssen TA, Wagener C, Obrink B . (2002). Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol 33: 290–298.
4. Chen T, Zimmermann W, Parker J, Chen I, Maeda A, Bolland S . (2001). Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals. J Leukoc Biol 70: 335–340.
5. Chen Z, Chen L, Baker K, Olszak T, Zeissig S, Huang YH et al. (2011). CEACAM1 dampens anti-tumor immunity by downregulation of NKG2D ligand expression on tumor cells and NKG2D function on NK cells. J Exp Med 208: 2633–2640.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献